Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Analysis of Saliva Provides Early Evidence of Oral Cancer

By Labmedica staff writers
Posted on 14 Apr 2008
A fibrous protein molecule known as cytokeratin 8 (CK8) in saliva is a potential cellular marker of premalignant changes in oral epithelial cells and of increased risk of cancer development.

Saliva samples were collected from eight subjects with oral cancer or a history of abnormal oral lesions and five healthy controls. More...
Participants brushed and rinsed with saline before providing the saliva sample containing cheek cells. Results showed that the percentage of cells with cytokeratin 8 was significantly higher in the cancer/abnormal samples than in samples from the normal controls.

Jennifer Frustino, a predoctoral student at the University at Buffalo School of Dental Medicine (Buffalo, NY, USA) and first author on the study, said that cytokeratin "has emerged recently as a potential cellular marker of premalignant changes in oral epithelial cells and of increased risk of cancer development. These markers are especially useful because they are abundant, stable, and easily stained and detected. Cytokeratin 8 expression is closely related to abnormalities of epithelial cells and shows a positive correlation with the development of head and neck squamous cell carcinoma.”

"This is the first study that detects CK8 as a biomarker through an easy collection method and simple analysis. The study is continuing and the results remain promising as more patients are enrolled.” concluded Ms. Faustino.

The preliminary study was conducted by investigators from the University of Buffalo, Roswell Park Cancer Institute (Buffalo, NY, USA) and Tufts University (Boston, MA, USAResults of the study were presented on April 4, 2008, at a poster session at the 2008 American Academy of Dental Research in Dallas (Texas, USA).


Related Links:
University at Buffalo School of Dental Medicine
Roswell Park Cancer Institute
Tufts University

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Automated MALDI-TOF MS System
EXS 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.